ClinConnect ClinConnect Logo
Search / Trial NCT04596514

Resuscitative Endovascular Balloon Occlusion of the Aorta in Non-traumatic Out of Hospital Cardiac Arrest

Launched by ST. OLAVS HOSPITAL · Oct 15, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Reboa Procedure Aortic Occlusion Resuscitation Pre Hospital Emergency Care

ClinConnect Summary

This clinical trial is studying a new treatment called Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) for patients who experience a sudden cardiac arrest outside of a hospital. Cardiac arrest is a serious condition where the heart stops beating, and immediate medical help is crucial. The goal of this trial is to see if using REBOA alongside standard life-saving measures, known as Advanced Cardiovascular Life Support (ACLS), can improve outcomes for these patients. REBOA works by temporarily blocking blood flow in a major artery to help redirect blood to vital organs during cardiopulmonary resuscitation (CPR), which may increase the chances of heart function returning.

To be eligible for this trial, participants must have experienced a non-traumatic cardiac arrest (not due to injury) and must have received basic or advanced life support within 10 minutes of the arrest. Patients who are pregnant, have certain medical conditions, or who have experienced traumatic cardiac arrests will not be included. If someone is chosen to participate, they can expect to receive the standard life-saving treatments along with the experimental REBOA procedure. This research could lead to better resuscitation methods in the future if the results show that REBOA is beneficial.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • out-of-hospital cardiac arrest
  • non-traumatic cardiac arrest
  • less than 10 minutes from debut of arrest to start of basic or advanced cardiac life support
  • advanced cardiac life support is established and can be continued
  • Exclusion Criteria:
  • traumatic cardiac arrest, including strangulation, electrocution and patients rescued from avalanches
  • accidental hypothermia with temperature \< 32 0C
  • suspected cerebral hemorrhage as etiology of the arrest
  • suspected non-traumatic hemorrhage as etiology of the arrest
  • pregnancy, obvious or suspected
  • patient included to the study site's E-CPR protocol
  • other factors as decided by the treatment team (environmental factors, safety factors and others)

About St. Olavs Hospital

St. Olavs Hospital is a leading healthcare institution located in Trondheim, Norway, renowned for its commitment to advancing medical research and improving patient care. As a key clinical trial sponsor, the hospital is dedicated to conducting innovative research across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With state-of-the-art facilities and a patient-centric approach, St. Olavs Hospital aims to enhance clinical outcomes and contribute to the global body of medical knowledge through rigorous and ethically conducted clinical trials.

Locations

Bergen, , Norway

Stavanger, , Norway

Drammen, , Norway

Trondheim, , Norway

Aarhus, , Denmark

Billund, , Denmark

Ringsted, , Denmark

Skive, , Denmark

Bologna, , Italy

Oslo, , Norway

Oslo, , Norway

Patients applied

0 patients applied

Trial Officials

Rune Wiseth, MD, PhD

Study Director

St Olav&amp;amp;#39;s Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials